The mission of our clinical research is to foster discoveries in the novel therapies of inflammatory bowel diseases, gastrointestinal and pancreatic cancer, hepatitis, and other gastrointestinal disorders. Our doctors are committed to providing the best care and management of diseases while testing cutting-edge therapies.
 |
Clinical Trials in the GI Unit
The clinical success of the Division of Gastroenterology is closely tied to its success in clinical research. The Division is currently directing more than 30 clinical trials that seek to improve the treatment and diagnosis of a wide range of gastrointestinal conditions. |
The following is a list of currently active clinical trials within the Division of Gastroenterology.
Conditions:
- Barrett’s esophagus (6)
- Cholangiocarcinoma and pancreatic cancer (1)
- Colorectal polyps and cancer (1)
- Crohn's disease (9)
- Cyclic vomiting (2)
- Diabetic gastroparesis (1)
- Diarrhea (1)
- Esophageal cancer (5)
- Gastric polyps (1)
- Gastroparesis (3)
- Hepatitis B (1)
- Hepatitis C (6)
- Hirschsprung's disease (1)
- HIV and Hepatitis C co-infection (2)
- Indeterminate colitis (3)
- Irritable bowel syndrome (1)
- Lysosomal acid lipase deficiency (LALD) (1)
- Liver disease (5)
- Neuroendocrine tumors (1)
- Non-alcoholic fatty liver disease (1)
- Non-alcoholic steatohepatitis (NASH) (2)
- Pancreatic cancer (6)
- Pancreatic cysts (4)
- Pancreatitis (1)
- Primary sclerosing cholangitis (1)
- Ulcerative colitis (4)
